Woodline Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
VCM
VPM
Woodline Partners's DXCM Position: Q1 2026 in Review
Woodline Partners increased its DexCom (DXCM) stake by 3.6% in Q1 2026, buying an estimated $1.24M and bringing the position to 513,321 shares worth $32.2M. The position accounts for 0.12% of the portfolio, ranked #225.
Woodline Partners first reported a position in DXCM in Q4 2019 and has held it in 22 quarters since. The position peaked at $63.3M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Woodline Partners held 513,321 shares of DexCom worth $32.2M as of Q1 2026.
- Woodline Partners bought 17,751 DexCom shares in Q1 2026, an estimated $1.24M.
- DexCom made up 0.12% of Woodline Partners's portfolio in Q1 2026, its #225 holding.
- Woodline Partners first reported a position in DexCom in Q4 2019 and has held it in 22 quarters since.
- Woodline Partners's DexCom position peaked at $63.3M in Q4 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.